AstraZeneca Settles Dangerous Drugs Lawsuit With Multiple States for $68.5 Million

AstraZeneca Settles Dangerous Drugs Lawsuit With Multiple States for $68.5 MillionThe London-based pharmaceutical company AstraZeneca has recently reached a settlement with 37 U.S. states and the District of Columbia to resolve claims about the company's drug, Seroquel.

The dangerous drugs lawsuit alleged that AstraZeneca deceptively marketed its anti-psychotic drug as treatment for a variety of conditions that it was not approved to treat by the U.S. Food and Drug Administration (FDA). Seroquel is only approved to treat schizophrenia and bipolar disorder, but the company also marketed it as a treatment for dementia, depression and anxiety in violation of federal law, the states claimed.

The company was also accused of failing to adequately disclose some of the side-effects associated with Seroquel, such as increased risk of diabetes and high blood sugar.

According to Paula Dow, attorney general of New Jersey, one of the 37 settling states, the settlement is the largest multi-state, consumer protection settlement with a drug manufacturer on record. According to Reuters, AstraZeneca's settlement does not include an admission of guilt by the company. Seven other states that had brought the litigation but did not participate in the settlement will continue their lawsuit, which the drugmaker has said it will "vigorously defend" itself from.